X4 Pharmaceuticals, Inc (XFOR) SEC Filings — 2025
19 SEC filings for X4 Pharmaceuticals, Inc (XFOR) in 2025.
Filings
- X4 Pharma's Revenue Soars, Net Loss Widens Amid Strategic Shift — 10-Q · Nov 5, 2025
- X4 Pharmaceuticals Enters Material Definitive Agreement — 8-K · Oct 27, 2025
- X4 Pharmaceuticals Files 8-K on Exit Costs and Personnel Changes — 8-K · Sep 17, 2025
- X4 Pharmaceuticals Announces Director and Officer Changes — 8-K · Aug 25, 2025
- X4 Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Aug 13, 2025
- X4 Pharmaceuticals Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Aug 12, 2025
- X4 Pharmaceuticals Reports Zero Revenue, Continues Capital Raises — 10-Q · Aug 8, 2025
- X4 Pharmaceuticals Files 8-K: Material Agreement & Exhibits — 8-K · Jun 23, 2025
- X4 Pharmaceuticals Files 8-K on Security Holder Vote Matters — 8-K · Jun 11, 2025
- X4 Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 1, 2025
- X4 Pharma Files DEF 14A: Executive Comp & Governance — DEF 14A · Apr 25, 2025
- X4 Pharmaceuticals Changes Fiscal Year End — 8-K · Apr 24, 2025
- X4 Pharmaceuticals Files 8-K on Security Holder Vote — 8-K · Apr 18, 2025
- X4 Pharmaceuticals Files 2024 10-K — 10-K · Mar 26, 2025
- X4 Pharmaceuticals Files 8-K on Operations — 8-K · Mar 25, 2025
- X4 Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Mar 24, 2025
- X4 Pharmaceuticals Updates Principal Executive Offices — 8-K · Mar 3, 2025
- X4 Pharmaceuticals Files 8-K on Exit Activities — 8-K · Feb 6, 2025
- X4 Pharmaceuticals Files 8-K: Material Agreement, Financials — 8-K · Jan 13, 2025